NASDAQ:NARI
Delisted

Inari Medical Stock News

etoro logo Buy NARI
*Your capital is at risk
$79.97
+0 (+0%)
At Close: May 16, 2025
Morgan Stanley increased its holdings in shares of Inari Medical, Inc. (NASDAQ:NARI) by 86.8% in the 2nd quarter, according to its most recent filing with the SEC. The fund owned 178,144 shares of the companys stock after purchasing an additional 82,802 shares during the period. Morgan Stanley owned approximately 0.36% of Inari Medical worth $16,617,000 []
The coronavirus pandemic is a "tipping point" for long-term trends that can make investors a lot of money, according to Alex Ely of Macquarie Asset Management.
LPL Financial LLC boosted its position in Inari Medical, Inc. (NASDAQ:NARI) by 29.4% in the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 4,748 shares of the companys stock after purchasing an additional 1,079 shares during the period. LPL Financial LLCs []
Inari Medical (NASDAQ:NARI) had its target price increased by SVB Leerink from $110.00 to $120.00 in a research report report published on Wednesday, Analyst Price Targets reports. The firm currently has an outperform rating on the stock. SVB Leerink also issued estimates for Inari Medicals Q4 2021 earnings at ($0.01) EPS, FY2021 earnings at $0.17 []

New Strong Sell Stocks for November 10th

09:57am, Wednesday, 10'th Nov 2021
AZN, GOLD, NARI, KOP, and TCEHY have been added to the Zacks Rank #5 (Strong Sell) List on November 10, 2021.
Inari Medical's (NARI) third-quarter results benefit from new product launches and continued U.S. commercial expansion.
Inari Medical, Inc.'s (NARI) CEO Bill Hoffman on Q3 2021 Results - Earnings Call Transcript

Recap: Inari Medical Q3 Earnings

04:34pm, Tuesday, 09'th Nov 2021
Inari Medical (NASDAQ:NARI) reported its Q3 earnings results on Tuesday, November 9, 2021 at 04:01 PM. Here's what investors need to know about the announcement.
IRVINE, Calif., Oct. 26, 2021 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a commercial-stage medical device company focused on developing products to treat and transform the
IRVINE, Calif., Oct. 18, 2021 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”) a medical device company focused on developing products to treat and transform the lives of patients
William Hoffman, President And CEO at Inari Medical (NASDAQ:NARI), made a large insider sell on October 7, according to a new SEC filing. What Happened: A Form 4 filing from the U.S. Securities and Ex
Investors continue to be optimistic about Inari Medical (NARI) owing to its focus on understanding the venous system and its commitment toward patient care.
Inari Medical, Inc. (NASDAQ: NARI) announced it has added Dana G. Mead, Jr. to its board of directors.
The Dow rose about 210 points, the S&P 500 rebounded by 0.6%, and the Nasdaq added another 0.6%. Find opportunities in today's market with the best short plays from Q.ai's deep learning algorithms.
Inari Medical, Inc. (NARI) reported earnings 30 days ago. What's next for the stock?
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE